Saliva
Saliva is an intervention with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease
Meteorin-like Levels in Individuals With Periodontitis
Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study
Interleukin-38 Levels in Individuals With Periodontitis
Salivary Calcium in Post-menopausal Women and Prevalence of Dental Caries
Clinical Trials (10)
AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease
Meteorin-like Levels in Individuals With Periodontitis
Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study
Interleukin-38 Levels in Individuals With Periodontitis
Salivary Calcium in Post-menopausal Women and Prevalence of Dental Caries
(NOD)-Like Receptors CARD Domain-Containing 4 Levels in Individuals With Periodontitis
MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial
Identification of Host Factors of Norovirus Infections in Mini-Gut Model
Saliva Profiles in Children With Congenital Heart Disease
Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections
All 10 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 10